Skip to main content
. 2024 Feb 2;39(6):350–360. doi: 10.1097/YIC.0000000000000536

Table 3.

Two-way frequency table showing participants’ GAD-7 classification at baseline and 12 months (n = 120)

GAD-7 score at 12 months Total
0–4
(minimal)
5-9
(mild)
10–14
(moderate)
15–21
(severe)
GAD-7 score at baseline 0–4 (minimal) 8 1 0 0 9(7.50%)
5–9
(mild)
5 13 0 0 18(15.00%)
10–14
(moderate)
4 3 22 3 32(26.67%)
15–21
(severe)
8 9 3 41 61(50.83%)
Total 25(20.83%) 26(21.67%) 25(20.83%) 44(36.67%) 120